Development of human embryonic stem cell therapies for age-related macular degeneration.

Highlights: [•] Age-related macular degeneration (AMD) is the leading cause of vision loss in older adults. Recent research for treating AMD has focused on replacing the retinal pigment epithelium (RPE), a monolayer of cells vital to photoreceptor cell health [•] Various methods are used to differentiate and purify RPE from human embryonic stem cells, and their efficacy as treatments are being tested in existing and forthcoming clinical trials. [ABSTRACT FROM AUTHOR]